CTN Dissemination Library

American Academy of Addiction Psychiatry (AAAP) Annual Meeting and Scientific Symposium
2026-11-12 - 2026-11-15 | The Peabody Memphis, 149 Union Ave., Memphis, TN, 38103, United States
This event provides the latest scientific developments in substance use disorders and co-occurring mental health disorders for psychiatrists, primary care physicians, and allied health professionals.
The goal of the conference is to recognize emerging issues and trends in Addiction Psychiatry and be on the forefront of the diagnosis and treatment of substance use disorders and co-occurring psychiatric disorders.

AMERSA Conference 2026
2026-11-12 - 2026-11-14 | Omni Shoreham Hotel, 2500 Calvert Street NW, Washington, DC, 20008, United States
AMERSA — the Association for Multidisciplinary Education and Research in Substance Use and Addiction — celebrates its 50th Annual Conference November 12–14, 2026 in Washington, DC. The program brings together physicians, nurses, pharmacists, social workers, counselors, researchers, peer recovery professionals, and people with lived and living experience with plenaries on emerging drugs of concern, contingency management, cannabis and psilocybin regulation, DC/Maryland policy innovation, and the evidence on GLP-1s. Early bird registration is open through August 31.

American Public Health Association (APHA) Annual Meeting
2026-11-01 - 2026-11-04 | Henry B. González Convention Center, 900 E. Market St., San Antonio, TX, 78205, United States
As the largest public health gathering of the year, APHA’s Annual Meeting and Expo convenes approximately 11,000 public health professionals and partners from around the world. Join APHA for this can’t-miss opportunity to make lasting connections and learn from exhibitors, peers and today’s leaders.
Early bird rates available until September 16, 2026.
View program | Register here

Addiction Health Services Research (AHSR) Conference
2026-10-05 - 2026-10-07 | The Little America Hotel, 500 South Main St., Salt Lake City, UT, 84101, United States
The Addiction Health Services Research (AHSR) conference brings together researchers, policymakers, and treatment providers to solve the problems of inequity, access, effectiveness, and implementation of addiction services.

Greater Southern CA Node: Guam's 7th Annual Behavioral Health & Addictions Virtual Conference
2026-09-23 15:00 - 2026-09-24 21:30 (America/Los_Angeles) | Webinar/Virtual
The Greater Southern California Node and its Pacific Southwest Addiction Technology Transfer Center (PSATTC) partners would like to invite you to Guam’s 7th Annual Behavioral Behavioral Health & Addictions Virtual Conference.

This FREE two-day virtual conference held in recognition of National Recovery Month will feature 4 plenary presentations and 4 breakout sessions, offering 8 concurrent workshop tracks.
Whether you are looking to strengthen your clinical practice, learn about emerging trends, or discover innovative approaches to providing care, this conference offers valuable education and practical strategies to support your work.
Sponsored by the Guam Behavioral Health and Wellness Center and the Pacific Southwest ATTC.

The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream
2026-09-18 09:00 - 16:30 (America/Los_Angeles) | UW Tower, 4333 Brooklyn Ave. NE, Seattle, WA, 98105, United States
CME accreditation for providers pending; a certificate of attendance will be available for all attendees (in-person or virtual)
Register here (for in-person and virtual attendance) | View program
In a recent survey of Washington State healthcare providers about cannabis negative effects, 70% of respondents reported seeing cases of severe abdominal pain, nausea, retching, and relentless vomiting among people reporting heavy cannabis use.
This cluster of symptoms is now recognized as Cannabinoid Hyperemesis Syndrome (CHS).
As CHS becomes more visible in clinical settings, providers are left navigating care without clear understanding or guidance. At the same time, while 1 in 10 Washingtonians who consumed cannabis in the last year report vomiting and nausea due to their cannabis use2, many people remain skeptical that the condition exists at all, creating challenges for treatment, prevention and health education.
To better understand these dynamics, we are making CHS the focus of this year’s ADAI Symposium.
Join the University of Washington’s Addictions, Drug & Alcohol Institute (home of the CTN Pacific NW Node) on September 18, 2026, to learn more about:

CHS prevalence among adolescents and adults in U.S. emergency departments
CHS in Washington State
CHS as a contested disease and implications for health communication
CHS presentation, treatment, and management across settings
Policy recommendations to prevent CHS increase
Improving care for individuals with CHS

HS Node: Factors Distinguishing Clinics That Successfully Increased OUD Treatment
2026-09-03 10:00 - 11:00 (America/Los_Angeles) | Webinar/Virtual
Join the Health Systems Node for this upcoming session, in which Tessa Matson, PhD, MPH, Collaborative Scientist at Kaiser Permanente Washington Health Research Institute, will present findings from a CTN implementation trial on factors that distinguished clinics that successfully increased opioid use disorder treatment from those that did not.
Connect:
Microsoft Teams. Meeting ID: 250 658 877 216 6 | Passcode: [REDACTED]

NAADAC Annual Conference (Association for Addiction Professionals)
2026-08-29 - 2026-08-31 | Sheraton Kansas City Hotel at Crown Center, 2345 McGee Street, Kansas City, MO, 64108, United States
Join over a thousand fellow addiction professionals at the Sheraton Kansas City Hotel at Crown Center in Kansas City, MO, for the 2026 NAADAC Annual Conference (theme: Empower 2026).
This immersive educational experience will provide you with addiction-specific CEs, fantastic networking opportunities, and the chance to learn about the latest advancements in the field. Join us in August and take part in interactive workshops, panel discussions, pre- and post-conference sessions, poster presentations, an exhibit hall, special events, networking opportunities, and so much more! Registration is now open!

OV Node: Towards Personalized Medicine for Opioid Use Disorder: Analyses of Data from the Veterans Health Administration
2026-08-12 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join host Ohio Valley Node PI T. John Winhusen, PhD, this summer for the University of Cincinnati/UC Health Addiction Center’s webinar series!
This series will highlight cutting-edge UC addiction research and UC-community collaborations focused on prevention and treatment.
The third and final installment of this series will feature Corey J. Hayes, PharmD, PhD, MPH (U. Arkansas) and Daniel Bebo, MD (U. Cincinnati) talking about personalized medicine for opioid use disorder.
Register here.

HS Node: Relationship Between Rapid Rehousing & Substance-Related Emergency Department Visits
2026-08-06 10:00 - 11:00 (America/Los_Angeles) | Webinar/Virtual
Join the Health Systems Node for this upcoming event at which Caitlin Ryus, MD, MPH, Assistant Professor in the Department of Emergency Medicine at Yale School of Medicine, will discuss a Connecticut-based study that links administrative data from homelessness services and electronic health records to examine the relationship between rapid rehousing and substance-related emergency department visits.
Connect:
Microsoft Teams. Meeting ID: 250 658 877 216 6 | Passcode: [REDACTED]

Harm Reduction International Conference
2026-07-23 08:00 - 17:00 (America/Los_Angeles) | ICC Belfast, 2 Lanyon Place, Belfast, BT1 3WH, Ireland
The Harm Reduction International Conference is convened by Harm Reduction International in a different city every two years. Over four days of presentations, workshops, films, networking events and more, the conference provides a dynamic forum to share the latest research and discussions on best practice in drug use, harm reduction and human rights and attracts a diverse group of over 1,000 delegates and speakers including front-line health workers, academics, researchers, policy makers, politicians, UN representatives, people who use drugs, sex workers and people working in the criminal legal system.

CTN Translation & Implementation SIG: SUD Treatment Research in the CTN: Portfolio Analysis of Approved Studies, 2000-2024
2026-07-21 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Join the CTN Translation & Implementation SIG for their next meeting, July 21, 2026, 9-10am PT.
Drs. Sabeeh Baig, Jeremiah Bertz, and Landhing Moran will describe the methods and findings from their comprehensive portfolio analysis of all studies within the CTN approved from 2000 through 2024. Their presentation will highlight scientific areas in the CTN portfolio, portfolio growth trends, and research impact through this period. The presentation will conclude with a discussion of the CTN’s achievements and the strengths of its trial infrastructure.
Read more about the speakers
Contact Elena Rosenberg-Carlson at rosenbee@stanford.edu for the meeting link or to join the CTN T&I email list.

OV Node: Characterizing Heavy Drinking in Midlife and Older Adults via Mixed Methods
2026-07-08 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join host Ohio Valley Node PI T. John Winhusen, PhD, this summer for the University of Cincinnati/UC Health Addiction Center’s webinar series!
This series will highlight cutting-edge UC addiction research and UC-community collaborations focused on prevention and treatment.
The second installment in the series will feature Victor Schneider, PhD, and Christian C. Garcia, PhD (both of U. Cincinnati) talking about heavy drinking in midlife and older adults.
Register here.

Greater Intermountain Node: Psychedelic-Assisted Interventions for Mental Health & Substance Use
2026-06-16 12:00 - 13:00 (America/Phoenix) | Webinar/Virtual
Join the Greater Intermountain Node on June 16, 2026 (12-1pm MST) for their next GIN on the Rocks webinar:
Psychedelic-Assisted Interventions for Mental Health and Substance Use: Current Evidence and Emerging Directions
Presenter: Yitong Xin, PhD
Psychedelic-assisted interventions have gained significant scientific and public attention, yet many researchers and clinicians remain unfamiliar with the current state of the evidence. This presentation will provide an accessible overview of psychedelic science and emerging clinical evidence across depression, trauma, and substance use, with Dr. Xin highlighting her research program’s contributions across multiple populations
and substances. The presentation concludes with a discussion of where the addiction research community can contribute.

About the speaker:
Yitong Xin, Ph.D., is an Assistant Professor at the College of Social Work, University of Utah. Her work focuses on clinical research at the intersection of mental health and substance use treatment, emphasizing harm reduction (e.g., psychedelic-assisted interventions) and strengths-based methodologies. Dr. Xin earned her Ph.D. from The Ohio State University, where she trained at the
Center for Psychedelic Drug Research and Education.
Join the Zoom:
Meeting ID: 835 8472 5058
Passcode: [REDACTED]

College on Problems of Drug Dependence (CPDD) Annual Meeting
2026-06-13 - 2026-06-17 | Oregon Convention Center, 777 NE Martin Luther King Jr. Blvd., Portland, OR, 97232, United States
2026’s CPDD conference will be held June 13-17, 2026 at the Oregon Convention Center in Portland, OR. Check the website for updates!

OV Node: Beyond Daily Dosing: Comparing Extended-Release and Sublingual Buprenorphine for Opioid Use Disorder in Pregnancy and Postpartum – Research Evidence and Lived Experience
2026-06-10 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join host Ohio Valley Node PI T. John Winhusen, PhD, this summer for the University of Cincinnati/UC Health Addiction Center’s webinar series!
This series will highlight cutting-edge UC addiction research and UC-community collaborations focused on prevention and treatment.
The first installment in the series will feature Dr. Winhusen and Recovery Advocate Kelsie Buchanan talking about extended-release and sublingual buprenorphine for OUD in pregnancy and postpartum.
Register here

Southwest Node: Partnering with Tribal Serving Programs to Enhance Culture in the Delivery of Substance Use Disorder Treatment
2026-06-09 11:00 - 12:00 (America/New_York) | Webinar/Virtual
This project (CTN-0096) looked at adding culture to care for Alaska Native and American Indian people who had problems with opioid use. The care was medication treatment. We wanted to see if culture would help more people start and stay in treatment. We worked with four clinics. We invited Alaska Native and American Indian people to be on our Collaborative Board to help us with this project. Two American Indian women led groups at each clinic. Each clinic chose its own way to include culture in medication treatment. After culture was added, Alaska Native and American Indian customer-owners were more likely to start treatment and more likely to stay in treatment. These results suggest that including culture can help improve services for Alaska Native and American Indian people.
Presenters: Kamilla Venner, PhD, and Aimee Campbell, PhD, MSW
View flyer
Join the Zoom session here
Meeting ID: 977 4576 0996
Passcode: [REDACTED]

Advancing Health Equity Addiction Research in Challenging Times (New Brunswick, NJ)
2026-05-22 11:00 - 15:30 (America/New_York) | Rutgers Institute for Health, 112 Paterson St., New Brunswick, NJ, United States
(NOTE: This is not CTN-related event but may be of interest to CTN members.)
Join the Rutgers Resilience Collective for this in-person event on May 22, 2026, 11am-3:30pm ET.
This conference is fere to attend. Lunch will be provided for attendees who register by April 15. Students and early-stage investigators may apply for travel awards and data blitz talks.
Keynote speaker: Sarah Pederson, PhD: For the Communities Counting on Us: Addiction Research Moves Forward

CTN Northeast Node: Injecting Hope: Repurposing GLP-1 Receptor Agonists for Treating SUDs
2026-05-21 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the CTN Northeast Node for the next installment of their virtual Science Series, featuring presenter Joji Suzuki, MD, FACLP, PI of the SuzukiLab at Brigham and Women’s Hospital, speaking about the use of GLP-1 receptor agonists for treatment substance use disorders (SUDs).
This 1-hour session on May 21, 2026 (12-1pm ET) will cover the basic pharmacology of GLP-1 receptor agonists and related medications. Then the emerging evidence-base for their use in treating substance use disorders in humans will be reviewed. Finally, the talk will cover the various issues and concerns that are now being raised when using GLP-1 receptor agonists.
Register here

American Psychiatric Association (APA) Annual Meeting
2026-05-16 - 2026-05-20 | MD
Join APA in May 2026 as they return to San Francisco for 4.5 days of engaging programming on the future of psychiatry!
Registration opens November 12, 2025.

American Society of Addiction Medicine (ASAM) Annual Conference
2026-04-23 - 2026-04-26 | Manchester Grand Hyatt, 1 Market Pl, San Diego, CA, 92101, United States
The ASAM Annual Conference is the defining event in addiction medicine, bringing together all professionals to connect, learn, and inspire. For 57 years, ASAM has been convening the addiction treatment community to showcase best practices and the latest science, research, and innovations in the field. This year, attendees will have the opportunity to:

Connect and network with over 2,500 colleagues
Learn from nationally recognized experts at 60+ sessions and 120+ posters
Be Inspired by thought-provoking conversations with peers and powerful presentations highlighting actionable and practical skills

CTN Annual Scientific and Steering Committee Meeting
2026-04-13 08:00 - 2026-04-15 17:00 UTC | Natcher Building, NIH, 45 Center Dr., Bethesda, MD, 20894, United States
The National Drug Abuse Treatment Clinical Trials Network (CTN) will hold its Annual Scientific and Steering Committee Meeting on Monday-Wednesday, April 13-15, 2026.
The meeting will be held at the Natcher Building on the NIH Campus in Bethesda, Maryland.
Find more information and register here!

Health System Node: Effects of Cannabis Legalization on Mental Health and Substance Use in Adults and Thoughts on Future Directions in Cannabis Research
2026-04-02 10:00 - 23:00 (America/Los_Angeles) | Webinar/Virtual
Dr. Christian Hopfer, Professor of Psychiatry at the University of Colorado School of Medicine and addiction psychiatrist, will briefly review the pharmacology of cannabinoids, present results of a recently completed study on the effects of cannabis legalization on mental health and substance use, and discuss ongoing projects including a randomized clinical trial of cannabidiol as a possible harm reduction intervention for cannabis use disorder in young adults. He will also discuss future directions for cannabis research with a particular emphasis on how large health system records could be leveraged to address critical questions in cannabis research.
Join the meeting now
Meeting ID: 250 658 877 216 6
Passcode: [REDACTED]

CTN Primary Care SIG: Conducting Substance Use Research in Prisons
2026-03-23 12:00 - 13:00 (America/New_York) | Webinar/Virtual
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.
Next Primary Care SIG Meeting
“Conducting substance use research in prisons”
Helen Jack, MD
Assistant Professor, University of Washington
Join Zoom Meeting here
Meeting ID: 943 3434 2090
Passcode: [REDACTED]

Northeast Node: Innovations in Opioid Use Disorder Treatment (webinar)
2026-02-26 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the Northeast Node for the next installment of their Science Series on February 26, 2026 (12-1pm ET)!
Presenter: Sarah Wakeman, MD
This session will review changes in the opioid overdose crisis and innovations in opioid use disorder treatment, including novel approaches to initiating buprenorphine, use of long-acting injectable buprenorphine, and strategies for methadone initiation in general medical settings.

Western States Node: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (CTN-0135)
2026-02-25 11:00 - 12:30 UTC | Webinar/Virtual
Join the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar!
In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl, including precipitated or prolonged withdrawal, patient reports that buprenorphine was ineffective, and patient preference for methadone. In response to these challenges, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes, seeing a high proportion of patients using fentanyl, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications.
1.5 CME/CE credits available! For information about credit types and accreditation, as well as learning objectives for this session, download the webinar flyer.

CTN Primary Care SIG: Whole-Person Primary Care for People Who Use Methamphetamine: Hearts, Lungs, Bugs, and Brains
2026-01-26 12:00 - 13:00 (America/New_York) | Webinar/Virtual
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.
In their next online meeting, Steven Shoptaw, PhD (UCLA) will present on “Whole-Person Primary Care for People Who Use Methamphetamine: Hearts, Lungs, Bugs, and Brains.”
Join Zoom Meeting
Meeting ID: 943 3434 2090
Passcode: [REDACTED]

CTN T&I SIG: A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings
2026-01-20 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Join the CTN Translation & Implementation (T&I) SIG on January 20, 2026 (9-10am PT) for their next virtual meeting, featuring guest speakers Camille Cioffi, PhD (Oregon Research Institute, University of OR), and Bryan Hartzler, PhD (Addictions, Drug & Alcohol Institute, University of WA)!

Stigma toward people with substance use disorders (SUD) remains a major barrier to care. In their session, titled, “A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings,” Drs. Cioffi and Hartzler will describe the methods, results, and implications of a scoping review completed by the CTN T&I SIG Implementation Strategies Workgroup to identify and describe implementation strategies used to reduce stigmatizing attitudes toward people with SUD in healthcare settings.

View flyer (png) to learn more about the presenters.

To request a link for the meeting, contact Elena Rosenberg-Carlson: rosenbee@stanford.edu

18th Annual Conference on the Science of Dissemination and Implementation in Health
2025-12-14 - 2025-12-17 | Gaylord National Resort & Convention Center, 201 Waterfront St., National Harbor, MD, 20745, United States
This December, individuals on the frontlines of dissemination and implementation (D&I) science will convene to ensure that evidence is used to inform decisions that will improve the health of individuals and communities.
Through a combination of plenaries, concurrent sessions, poster presentations, and workshops, the 18th Annual Conference on the Science of Dissemination and Implementation in Health, co-hosted by the National Institutes of Health (NIH) and AcademyHealth, supports the collective understanding of the research agenda, puts forth new findings, and identifies research priorities to set the field up for the next decade.
2025 Conference Theme
Realizing the Benefits of Dissemination & Implementation Science
This year’s conference theme will address our existing and future efforts to maximize the benefits of D&I science. While our field has identified and tested a range of strategies to ensure the adoption, integration, sustainment, and spread of effective health interventions, less attention has been focused on the ultimate benefits of successful dissemination and implementation studies. The 18th Annual Science of D&I Conference will explore success stories, methodological advancements, challenges, and opportunities to realize the benefits of our science across health care, community, and public health systems.

CTN Youth SIG Webinar: Advancing Equity Through Implementation Science in Adolescent Substance Use Prevention
2025-11-21 11:00 - 12:00 (America/New_York) | Webinar/Virtual
Join the CTN Youth SIG for their next webinar, Friday, November 21, 2025 (11:00 a.m.–12:00 p.m. ET), featuring Cady Berkel on “Advancing Equity Through Implementation Science in Adolescent Substance Use Prevention.”
Presenter:
Cady Berkel, PhD
Associate Professor
College of Health Solutions
Arizona State University
Culturally and contextually grounded preventive interventions can address upstream risk and protective factors to improve equity, but only if they are implemented in systems that serve underrepresented groups. This presentation will share findings a program of community-based research conducted in partnership with multiple settings (e.g., pediatric primary care, family courts, corrections) to advance equitable access to evidence-based substance use prevention for adolescents and families. The talk will also discuss implementation science frameworks and designs to incorporate equity and accelerate the translation of research into practice.
About the speaker:
Dr. Cady Berkel is an Associate Professor in the College of Health Solutions at Arizona State University whose program of federally funded research focuses on advancing equitable access to evidence-based substance use prevention for adolescents and families. Her work to embed parenting interventions in primary care was recognized by NIDA’s Substance Use Prevention Services in Primary Care Challenge. She also serves in national leadership roles, including as a National Advisory Council member for SAMHSA’s Center for Substance Abuse Prevention, a Subject Matter Expert for the CDC’s Community Preventive Services Task Force review of substance use prevention, and Co-Chair of the Society for Prevention Research Standards of Evidence Task Force.
Register here
